AXGT - Axovant Gene Therapies Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts6566
Avg. Estimate-1.72-1.6-9.51-6.69
Low Estimate-2.24-2.32-9.92-10
High Estimate-1.28-1.2-8.96-5.12
Year Ago EPS-1.84-3.84-16.48-9.51
Revenue EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts6566
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History3/30/20186/29/20189/29/201812/30/2018
EPS Est.-2.91-1.47-2.92-2.08
EPS Actual-1.84-3.84-2.24-2.16
Difference1.07-2.370.68-0.08
Surprise %36.80%-161.20%23.30%-3.80%
EPS TrendCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Current Estimate-1.72-1.6-9.51-6.69
7 Days Ago-1.72-1.6-9.51-6.69
30 Days Ago-1.72-1.6-9.51-6.69
60 Days Ago-0.22-0.21-1.19-0.86
90 Days Ago-0.24-0.22-1.13-0.95
EPS RevisionsCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesAXGTIndustrySectorS&P 500
Current Qtr.6.50%N/AN/A0.02
Next Qtr.58.30%N/AN/A0.04
Current Year42.30%N/AN/A0.05
Next Year29.70%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A